Author:
Hekmatshoar Y.,Ozkan T.,Karabay A.Z.,Koc A.,Gurel A. Karadag,Vignais M.-L.,Sunguroglu A.
Reference4 articles.
1. ‘Characterization of imatinib-resistant K562 cell line displaying resistance mechanisms’;Hekmatshoar;Cellular and molecular biology, 15,2018
2. ‘ Phenotypic and functional characterization of subpopulation of Imatinib resistant chronic myeloid leukemia cell line’;Hekmatshoar;Advances in Medical Sciences,2023
3. ‘Preclinical characterization of mitochondria-targeted small molecule hsp90 inhibitors, gamitrinibs, in advanced prostate cancer’;Kang,;Clinical Cancer Research,2010
4. ‘ Feasibility and safety of targeting mitochondria for cancer therapy – preclinical characterization of gamitrinib, a first-in-class, mitochondriaL-targeted small molecule Hsp90 inhibitor’;Umar;Cancer Biology & Therapy,2022